Insmed Other Stockholder Equity vs Non Currrent Assets Other Analysis

INSM Stock

USD 79.31 0.64 0.81%

Insmed financial indicator trend analysis is infinitely more than just investigating Insmed Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Insmed Inc is a good investment. Please check the relationship between Insmed Other Stockholder Equity and its Non Currrent Assets Other accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Other Stockholder Equity vs Non Currrent Assets Other

Other Stockholder Equity vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Insmed Inc Other Stockholder Equity account and Non Currrent Assets Other. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Insmed's Other Stockholder Equity and Non Currrent Assets Other is 0.94. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Insmed Inc, assuming nothing else is changed. The correlation between historical values of Insmed's Other Stockholder Equity and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Insmed Inc are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Other Stockholder Equity i.e., Insmed's Other Stockholder Equity and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Other Stockholder Equity

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most indicators from Insmed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Insmed Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

At this time, Insmed's Selling General Administrative is very stable compared to the past year. As of the 18th of February 2025, Tax Provision is likely to grow to about 3.1 M, while Issuance Of Capital Stock is likely to drop about 250.4 M.

Insmed fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Other Liab	Other Assets	Good Will	Non Current Liabilities Total	Intangible Assets
Total Assets		0.93	0.96	-0.51	0.91	0.7	-0.97	0.93	0.89	0.97	0.93	0.99	0.88	0.96	0.71	0.74	0.98	0.96	0.92	0.99	0.96	0.9	0.9	0.92	0.95	0.58
Other Current Liab	0.93		0.97	-0.73	0.78	0.85	-0.93	0.97	0.7	0.92	0.97	0.9	0.77	0.92	0.87	0.57	0.93	0.98	0.87	0.91	0.93	0.85	0.89	0.92	0.97	0.51
Total Current Liabilities	0.96	0.97		-0.69	0.9	0.84	-0.97	0.99	0.75	0.96	0.98	0.93	0.83	0.97	0.85	0.67	0.98	0.99	0.96	0.95	0.97	0.86	0.93	0.91	0.99	0.5
Total Stockholder Equity	-0.51	-0.73	-0.69		-0.45	-0.95	0.58	-0.71	-0.11	-0.58	-0.76	-0.43	-0.31	-0.55	-0.92	-0.04	-0.55	-0.74	-0.62	-0.47	-0.54	-0.47	-0.59	-0.61	-0.74	-0.1
Property Plant And Equipment Net	0.91	0.78	0.9	-0.45		0.66	-0.92	0.86	0.79	0.9	0.86	0.88	0.83	0.9	0.64	0.81	0.93	0.87	0.97	0.9	0.9	0.79	0.86	0.76	0.86	0.42
Net Debt	0.7	0.85	0.84	-0.95	0.66		-0.75	0.85	0.3	0.78	0.9	0.61	0.5	0.74	0.98	0.29	0.75	0.87	0.81	0.65	0.74	0.68	0.72	0.78	0.88	0.28
Retained Earnings	-0.97	-0.93	-0.97	0.58	-0.92	-0.75		-0.95	-0.81	-0.95	-0.94	-0.94	-0.91	-0.97	-0.76	-0.73	-0.98	-0.95	-0.94	-0.96	-0.97	-0.87	-0.93	-0.89	-0.95	-0.56
Accounts Payable	0.93	0.97	0.99	-0.71	0.86	0.85	-0.95		0.7	0.93	0.97	0.89	0.8	0.95	0.86	0.67	0.96	0.97	0.93	0.91	0.96	0.83	0.9	0.89	0.97	0.48
Cash	0.89	0.7	0.75	-0.11	0.79	0.3	-0.81	0.7		0.77	0.67	0.94	0.85	0.79	0.32	0.74	0.81	0.73	0.7	0.92	0.81	0.74	0.77	0.7	0.73	0.55
Non Current Assets Total	0.97	0.92	0.96	-0.58	0.9	0.78	-0.95	0.93	0.77		0.96	0.92	0.83	0.94	0.78	0.74	0.96	0.96	0.93	0.94	0.94	0.95	0.85	0.96	0.96	0.59
Non Currrent Assets Other	0.93	0.97	0.98	-0.76	0.86	0.9	-0.94	0.97	0.67	0.96		0.88	0.77	0.92	0.9	0.6	0.94	0.99	0.94	0.91	0.93	0.88	0.87	0.93	0.99	0.47
Cash And Short Term Investments	0.99	0.9	0.93	-0.43	0.88	0.61	-0.94	0.89	0.94	0.92	0.88		0.89	0.93	0.64	0.71	0.95	0.92	0.87	1.0	0.94	0.85	0.9	0.87	0.92	0.57
Common Stock Total Equity	0.88	0.77	0.83	-0.31	0.83	0.5	-0.91	0.8	0.85	0.83	0.77	0.89		0.88	0.53	0.74	0.88	0.79	0.81	0.89	0.89	0.75	0.83	0.76	0.79	0.66
Common Stock Shares Outstanding	0.96	0.92	0.97	-0.55	0.9	0.74	-0.97	0.95	0.79	0.94	0.92	0.93	0.88		0.77	0.72	0.99	0.94	0.94	0.95	1.0	0.83	0.94	0.89	0.93	0.61
Short Term Investments	0.71	0.87	0.85	-0.92	0.64	0.98	-0.76	0.86	0.32	0.78	0.9	0.64	0.53	0.77		0.28	0.77	0.87	0.8	0.67	0.77	0.66	0.74	0.8	0.87	0.35
Other Current Assets	0.74	0.57	0.67	-0.04	0.81	0.29	-0.73	0.67	0.74	0.74	0.6	0.71	0.74	0.72	0.28		0.76	0.59	0.72	0.73	0.71	0.75	0.59	0.59	0.58	0.41
Other Stockholder Equity	0.98	0.93	0.98	-0.55	0.93	0.75	-0.98	0.96	0.81	0.96	0.94	0.95	0.88	0.99	0.77	0.76		0.95	0.95	0.96	0.99	0.88	0.93	0.91	0.95	0.58
Total Liab	0.96	0.98	0.99	-0.74	0.87	0.87	-0.95	0.97	0.73	0.96	0.99	0.92	0.79	0.94	0.87	0.59	0.95		0.93	0.94	0.94	0.87	0.91	0.93	1.0	0.49
Property Plant And Equipment Gross	0.92	0.87	0.96	-0.62	0.97	0.81	-0.94	0.93	0.7	0.93	0.94	0.87	0.81	0.94	0.8	0.72	0.95	0.93		0.9	0.94	0.81	0.89	0.83	0.93	0.42
Total Current Assets	0.99	0.91	0.95	-0.47	0.9	0.65	-0.96	0.91	0.92	0.94	0.91	1.0	0.89	0.95	0.67	0.73	0.96	0.94	0.9		0.96	0.86	0.91	0.88	0.94	0.57
Common Stock	0.96	0.93	0.97	-0.54	0.9	0.74	-0.97	0.96	0.81	0.94	0.93	0.94	0.89	1.0	0.77	0.71	0.99	0.94	0.94	0.96		0.84	0.94	0.9	0.94	0.61
Other Liab	0.9	0.85	0.86	-0.47	0.79	0.68	-0.87	0.83	0.74	0.95	0.88	0.85	0.75	0.83	0.66	0.75	0.88	0.87	0.81	0.86	0.84		0.72	0.93	0.87	0.56
Other Assets	0.9	0.89	0.93	-0.59	0.86	0.72	-0.93	0.9	0.77	0.85	0.87	0.9	0.83	0.94	0.74	0.59	0.93	0.91	0.89	0.91	0.94	0.72		0.79	0.9	0.45
Good Will	0.92	0.92	0.91	-0.61	0.76	0.78	-0.89	0.89	0.7	0.96	0.93	0.87	0.76	0.89	0.8	0.59	0.91	0.93	0.83	0.88	0.9	0.93	0.79		0.93	0.7
Non Current Liabilities Total	0.95	0.97	0.99	-0.74	0.86	0.88	-0.95	0.97	0.73	0.96	0.99	0.92	0.79	0.93	0.87	0.58	0.95	1.0	0.93	0.94	0.94	0.87	0.9	0.93		0.48
Intangible Assets	0.58	0.51	0.5	-0.1	0.42	0.28	-0.56	0.48	0.55	0.59	0.47	0.57	0.66	0.61	0.35	0.41	0.58	0.49	0.42	0.57	0.61	0.56	0.45	0.7	0.48

Click cells to compare fundamentals

Insmed Account Relationship Matchups

Insmed fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	796.2M	1.2B	1.7B	1.3B	1.5B	1.6B
Other Current Liab	50.8M	79.1M	131.7M	149.6M	172.0M	180.6M
Total Current Liabilities	118.8M	135.2M	190.2M	225.6M	259.5M	272.4M
Total Stockholder Equity	275.9M	410.5M	88.0M	(331.9M)	(381.7M)	(362.6M)
Property Plant And Equipment Net	97.2M	95.5M	102.1M	104.4M	120.0M	126.0M
Net Debt	(127.9M)	(104.5M)	103.8M	721.6M	829.9M	871.4M
Retained Earnings	(1.8B)	(2.3B)	(2.7B)	(3.4B)	(3.1B)	(2.9B)
Accounts Payable	42.9M	35.8M	50.5M	65.4M	75.2M	79.0M
Cash	532.8M	716.8M	1.1B	482.4M	554.7M	582.5M
Non Current Assets Total	173.3M	406.5M	383.1M	400.8M	460.9M	483.9M
Non Currrent Assets Other	26.8M	51.0M	76.1M	96.6M	111.1M	116.6M
Cash And Short Term Investments	532.8M	716.8M	1.1B	780.4M	897.5M	942.4M
Common Stock Total Equity	897K	1.0M	1.2M	1.4M	1.6M	804.3K
Common Stock Shares Outstanding	97.6M	112.1M	123.0M	140.4M	161.5M	169.6M
Liabilities And Stockholders Equity	796.2M	1.2B	1.7B	1.3B	1.5B	1.6B
Other Current Assets	48.0M	57.8M	25.5M	24.2M	27.8M	29.2M
Other Stockholder Equity	2.1B	2.7B	2.8B	3.1B	3.6B	3.8B
Total Liab	520.3M	833.0M	1.6B	1.7B	1.9B	2.0B
Property Plant And Equipment Gross	97.2M	95.5M	102.1M	149.0M	171.4M	179.9M
Total Current Assets	622.9M	837.0M	1.3B	929.1M	1.1B	1.1B
Accumulated Other Comprehensive Income	193K	968K	756K	(745K)	(670.5K)	(704.0K)
Common Stock	1.0M	1.2M	1.4M	1.5M	1.7M	1.8M
Other Assets	72.5M	70.0M	51.0M	113.7M	130.7M	137.3M
Good Will	58.7M	53.7M	49.3M	136.1M	156.5M	164.4M
Non Current Liabilities Total	401.5M	697.9M	1.4B	1.4B	1.7B	1.7B
Intangible Assets	49.3M	73.8M	68.8M	63.7M	73.3M	61.3M
Property Plant Equipment	60.2M	54.0M	53.0M	56.5M	65.0M	68.2M
Net Receivables	16.6M	24.4M	29.7M	41.2M	47.4M	49.7M
Short Term Debt	25.1M	20.3M	8.1M	10.6M	12.2M	14.2M
Short Long Term Debt Total	404.8M	612.3M	1.2B	1.2B	1.4B	1.5B
Long Term Debt	356.3M	566.6M	1.1B	1.2B	1.3B	1.4B
Inventory	49.6M	67.0M	69.9M	83.2M	95.7M	100.5M
Net Tangible Assets	208.0M	226.6M	200.5M	(116.9M)	(134.5M)	(127.7M)
Retained Earnings Total Equity	(1.5B)	(1.8B)	(2.3B)	(2.7B)	(2.4B)	(2.3B)
Capital Surpluse	1.8B	2.1B	2.7B	2.8B	3.2B	3.4B
Deferred Long Term Liab	52.1M	47.3M	72.0M	37.6M	43.2M	45.7M
Non Current Liabilities Other	45.1M	131.3M	208.5M	242.8M	279.2M	293.2M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:

How To Invest In Insmed

Details

Is Insmed Stock a good investment?

Details

What is Insmed's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.55)

Revenue Per Share

2.206

Quarterly Revenue Growth

0.182

Return On Assets

(0.26)

Return On Equity

(8.91)

The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Insmed Other Stockholder Equity vs Non Currrent Assets Other Analysis

Other Stockholder Equity vs Non Currrent Assets Other

Other Stockholder Equity vs Non Currrent Assets Other Correlation Analysis

Correlation Coefficient

Other Stockholder Equity

Non Currrent Assets Other

Insmed fundamental ratios Correlations

Insmed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Insmed fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Shares Outstanding
Non Current Liabilities Total	+ 1.0	Total Liab
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Total Current Liabilities

Other Stockholder Equity	- 0.98	Retained Earnings
Common Stock	- 0.97	Retained Earnings
Common Stock Shares Outstanding	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Total Current Liabilities
Retained Earnings	- 0.97	Total Assets
Total Current Assets	- 0.96	Retained Earnings